Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia ; volume:11 ; number:1 ; day:24 ; month:6 ; year:2016 ; pages:1-17 ; date:12.2016
Molecular neurodegeneration ; 11, Heft 1 (24.6.2016), 1-17, 12.2016
- Urheber
-
Holler, Christopher J.
- Beteiligte Personen und Organisationen
-
Taylor, Georgia
McEachin, Zachary T.
Deng, Qiudong
Watkins, William J.
Hudson, Kathryn
Easley, Charles A.
Hu, William T.
Hales, Chadwick M.
Rossoll, Wilfried
Bassell, Gary J.
Kukar, Thomas
SpringerLink (Online service)
- DOI
-
10.1186/s13024-016-0114-3
- URN
-
urn:nbn:de:1111-2016082911362
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Holler, Christopher J.
- Taylor, Georgia
- McEachin, Zachary T.
- Deng, Qiudong
- Watkins, William J.
- Hudson, Kathryn
- Easley, Charles A.
- Hu, William T.
- Hales, Chadwick M.
- Rossoll, Wilfried
- Bassell, Gary J.
- Kukar, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency
Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency
Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency
Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice